Augmont Enterprises IPO entered its second day with strong demand, reaching 2.74 times subscription on Day 1. GMP climbed to 48%, indicating potential listing gains. The Rs 825 crore issue benefits from an integrated gold and silver ecosystem, strong financial growth and positive brokerage views, though valuation and working-capital risks remain.

Augmont Enterprises has raised Rs 246.29 crore from 14 anchor investors ahead of its IPO, allotting 31.25 lakh shares at Rs 788 each. Mutual funds accounted for 44.27% of the…

Augmont Enterprises IPO opens today, August 21, featuring a Rs 825 crore issue

The non-institutional investor (NII) category led with 3.97x subscription, driven by the sub-₹10 lakh NII bucket which was subscribed 5.82 times.

Today marks the end of bidding for Augmont Enterprises' IPO, which has attracted considerable interest from investors. The grey market premium forecasts promising gains upon…

Symbiotec Pharmalab IPO enters its second day with 80% subscription and a 34% GMP, indicating strong listing expectations. The Rs 1,757 crore issue offers specialised API and…